Published • loading... • Updated
Annovis Regains NYSE Compliance Ahead of Listing Deadline
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Annovis Regains NYSE Compliance Ahead of Listing Deadline
MALVERN, PA — Annovis Bio (NYSE: ANVS) has regained compliance with New York Stock Exchange listing standards a year after falling below required market capitalization and stockholders’ equity thresholds, removing a potential overhang as the biotechnology company approaches key clinical and regulatory milestones. The company said the NYSE confirmed that Annovis now meets all continued listing requirements after a series of measures designed to r…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
